Global Director Molecular and Cell Biology
Celerion
Lincoln, Nebraska
Johannes Stanta, PhD, works at Celerion as the Global Director of Molecular & Cellular Biology (MCB) being in charge of the Lincoln, NE and Zürich, Switzerland MCB laboratories at Celerion, INC. In this role, Johannes strengthens Celerion’s service offering with GLP and GCP compliant molecular and cell biology testing to support the development of new modality therapies, such as cell and gene therapies. He previously worked at Freeline Therapeutics as Director of Bioanalysis where he has the overall bioanalytical responsibility of several gene therapy clinical trials, including the companion diagnostic analytical and clinical development. He previously worked in senior scientific leadership roles in bioanalysis and clinical laboratory at LabCorp and Hammersmith Medicines Research. He received his PhD from the University of Cambridge, focusing on the discovery of diagnostic biomarkers for neuropsychiatric disorders. He has hands-on industry experience in small and large molecule bioanalytical assay development, validation and sample analysis, supporting clinical and non-clinical programs.
Disclosure information not submitted.
AAV8 Shedding Assay to Support Gene Therapy Clinical Trials
Thursday, May 16, 2024
9:30 AM – 10:00 AM PT